408 related articles for article (PubMed ID: 22991081)
1. [Variability in the reporting of adverse reactions to the pandemic and seasonal influenza vaccine: seasons 2009-2010 and 2010-2011. Valencian community, Spain].
Alguacil Ramos AM; Lluch Rodrigo JA; Portero Alonso A; Martín Ivorra R; Pastor Villalba E
Rev Esp Salud Publica; 2012; 86(3):241-51. PubMed ID: 22991081
[TBL] [Abstract][Full Text] [Related]
2. Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations.
Banzhoff A; Haertel S; Praus M
Hum Vaccin; 2011 May; 7(5):539-48. PubMed ID: 21422814
[TBL] [Abstract][Full Text] [Related]
3. Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.
Kurz X; Domergue F; Slattery J; Segec A; Szmigiel A; Hidalgo-Simon A
Vaccine; 2011 Jun; 29(26):4378-87. PubMed ID: 21501644
[TBL] [Abstract][Full Text] [Related]
4. Allergic adverse events following 2015 seasonal influenza vaccine, Victoria, Australia.
Clothier HJ; Crawford N; Russell MA; Buttery JP
Euro Surveill; 2017 May; 22(20):. PubMed ID: 28552101
[TBL] [Abstract][Full Text] [Related]
5. Annual report: surveillance of adverse events following immunisation in Australia, 2009.
Mahajan D; Roomiani I; Gold MS; Lawrence GL; McIntyre PB; Menzies RI
Commun Dis Intell Q Rep; 2010 Sep; 34(3):259-76. PubMed ID: 21090181
[TBL] [Abstract][Full Text] [Related]
6. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.
Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M
Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798
[TBL] [Abstract][Full Text] [Related]
7. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.
Halsey NA; Griffioen M; Dreskin SC; Dekker CL; Wood R; Sharma D; Jones JF; LaRussa PS; Garner J; Berger M; Proveaux T; Vellozzi C; ; Broder K; Setse R; Pahud B; Hrncir D; Choi H; Sparks R; Williams SE; Engler RJ; Gidudu J; Baxter R; Klein N; Edwards K; Cano M; Kelso JM
Vaccine; 2013 Dec; 31(51):6107-12. PubMed ID: 24120547
[TBL] [Abstract][Full Text] [Related]
8. Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain.
Larrauri A; Savulescu C; Jiménez-Jorge S; Pérez-Breña P; Pozo F; Casas I; Ledesma J; de Mateo S;
Gac Sanit; 2011; 25(1):23-8. PubMed ID: 21334788
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.
Hardelid P; Fleming DM; McMenamin J; Andrews N; Robertson C; SebastianPillai P; Ellis J; Carman W; Wreghitt T; Watson JM; Pebody RG
Euro Surveill; 2011 Jan; 16(2):. PubMed ID: 21251487
[TBL] [Abstract][Full Text] [Related]
10. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
Vellozzi C; Broder KR; Haber P; Guh A; Nguyen M; Cano M; Lewis P; McNeil MM; Bryant M; Singleton J; Martin D; DeStefano F
Vaccine; 2010 Oct; 28(45):7248-55. PubMed ID: 20850534
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K
BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542
[TBL] [Abstract][Full Text] [Related]
12. Active surveillance of adverse events following immunization against pandemic influenza A (H1N1) in Korea.
Choe YJ; Cho H; Song KM; Kim JH; Han OP; Kwon YH; Bae GR; Lee HJ; Lee JK
Jpn J Infect Dis; 2011; 64(4):297-303. PubMed ID: 21788704
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial.
Vajo Z; Tamas F; Sinka L; Jankovics I
Lancet; 2010 Jan; 375(9708):49-55. PubMed ID: 20018367
[TBL] [Abstract][Full Text] [Related]
14. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.
Castilla J; Morán J; Martínez-Artola V; Fernández-Alonso M; Guevara M; Cenoz MG; Reina G; Alvarez N; Arriazu M; Elía F; Salcedo E; Barricarte A;
Vaccine; 2011 Aug; 29(35):5919-24. PubMed ID: 21723358
[TBL] [Abstract][Full Text] [Related]
16. Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009-2010 season in the active component U.S. military and civilians aged 17-44years reported to the Vaccine Adverse Event Reporting System.
Bardenheier BH; Duderstadt SK; Engler RJ; McNeil MM
Vaccine; 2016 Aug; 34(37):4406-14. PubMed ID: 27449076
[TBL] [Abstract][Full Text] [Related]
17. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
[TBL] [Abstract][Full Text] [Related]
18. [Safety and epidemiological effects of the first China-made mass A (H1N1) influenza vaccination].
Ji WY; Lu L; Lü M; Miao L; Gao T; Huang RG; Suo LD; Liu DL; Ma R; Yu R; Zhangzhu JZ; Liu WX; Zeng Y; Li XM; Wu J
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 May; 31(5):481-4. PubMed ID: 21163019
[TBL] [Abstract][Full Text] [Related]
19. Tolerability of 2 doses of pandemic influenza vaccine (Focetria®) and of a prior dose of seasonal 2009-2010 influenza vaccination in the Netherlands.
van der Maas NA; Godefrooij S; Vermeer-de Bondt PE; de Melker HE; Kemmeren J
Hum Vaccin Immunother; 2016 Apr; 12(4):1027-32. PubMed ID: 26809939
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11.
Pebody R; Hardelid P; Fleming D; McMenamin J; Andrews N; Robertson C; Thomas D; Sebastianpillai P; Ellis J; Carman W; Wreghitt T; Zambon M; Watson J
Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
